November 9, 2015

Registration is now open
Join us for the NRG Oncology Semiannual Meeting, January 21-24, 2016 at the Atlanta Marriott Marquis in Atlanta, GA. Please pre-register online for this meeting. Registering onsite at the meeting will incur an additional $50 fee. Online Registration and meeting information is available on the NRG Oncology website.

GOG-0283: Reactivation effective November 9, 2015.Version Date: October 6, 2015

GOG-0250: Terminated effective September 29, 2015. Version Date: June 20, 2014

Sites in Canada: Health Canada documents are now available for Select NRG studies on the CTSU website. Please see the memo on the CTSU website.

RTOG 0834: Dear Investigator Letter dated November 9, 2015; also available on the CTSU website.

RTOG 0837: Statistical analyses for the primary and all secondary endpoints are being conducted. Your help by submitting any pending data would greatly assist in this process. Please review the patients’ calendar and submit any pending forms as soon as possible.

RTOG 1010: Reminder - This study will close to STEP 1 registration at 5 PM EST on Tuesday, November 10, 2015, and STEP 2 registration will remain open so eligible patients can be randomized for treatment. For details see the RTOG 1010 Closure Notice (dated October 27, 2015) on the CTSU website.

GOG-0274/RTOG-1174: OUTBACK Progress Report - October 2015

Vision Tree Webinar
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001 and NRG-HN002. Space is limited so register now and reserve your seat. The next webinar training is scheduled for December 16, 2015.

Safety updates have been issued for GOG legacy studies. For details, please see the GOG Weekly Mailing page.

Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP Members’ Area or the E-mail Distributions page and the CTSU website.

Safety updates have been issued for RTOG legacy studies. For details, please see the RTOG General Broadcast page.

Safety updates have been issued for the following NRG Oncology studies:
Nivolumab: NRG-GY002, NRG-GY003, NRG-BN002
Ipilimumab: NRG-GY003, NRG-BN002
For NRG-GY002 and NRG-GY003 safety reports, please see the protocol page on the NRG Oncology website for details.
For NRG-BN002 safety reports, please see the RTOG General Broadcast page for details.

Applications for membership in the GI Colorectal and GI Non-colorectal Subcommittees will be accepted until November 16, 2015. Please note that current committee members MUST re-apply for committee membership. If you or someone at your site is interested in becoming a committee member, please submit the application on or before November 16, 2015. The application is available on the NRG Oncology website: under the Scientific Program tab on the Disease Site Committees page. If you have any questions, please contact Carmen Allegra, MD ( or Christopher Crane, MD (

The NRG Oncology Biospecimen Bank – San Francisco will be closed Wednesday November 11th in observance of the UCSF Veterans Day Holiday. We will have one staff member on site but no shipments can be delivered as the building is officially closed. We request that sites do not ship frozen specimens to us on Tuesday the 10th, and that Canadian sites wait to ship frozen samples until the following week (November 17th).
Please contact us at or 415-476-7864 with any questions about this closure.

NRG Oncology Biospecimen Banks will be closed for the Thanksgiving Holiday, Thursday, November 26. On Fri., Nov 27 the San Francisco, Pittsburgh, and the Baylor NRG banks will remain closed; the Columbus bank will be open for business. See the memorandum posted on the NRG and CTSU websites for specimen shipment dates and additional details.

The NRG Oncology and Legacy NSABP websites will be unavailable on Saturday, November 14, from 8:00 AM to 2:00 PM for scheduled maintenance.

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

Gavin PG, Song N, Kim SR, Pogue-Geile KL, Paik S. Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls. J Clin Oncol. 2015 Nov 1;33(31):3671-2. doi: 10.1200/JCO.2015.61.9650. Epub 2015 Aug 17. PubMed PMID: 26282639. Read more LTE to accompanying article: Perez EA, et al. Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial. J Clin Oncol. 2015 Mar 1;33(7):701-8. PubMed ID: 25605861.

Jatoi I, Bandos H, Jeong JH, Anderson WF, Romond EH, Mamounas EP, Wolmark N. Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy. J Natl Cancer Inst. 2015 Oct 30;108(1). pii: djv304. doi: 10.1093/jnci/djv304. Print 2016 Jan. PubMed PMID: 26518884. Read more

Minasian LM, Tangen CM, Wickerham DL. Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program. Semin Oncol. 2015 Oct;42(5):748-63. doi: 10.1053/j.seminoncol.2015.07.006. Epub 2015 Jul 10. Review. PubMed PMID: 26433556; PubMed Central PMCID: PMC4593316. Read more

Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming abstract submission deadlines

American Radium Society (ARS), Apr 16-19, 2016, Philadelphia, PA, meeting abstract submission deadline Nov 20, 2015

American Urology Association (AUA); May 7-10, 2016; San Diego, CA; meeting abstract submission deadline Nov 9, 2015

Digestive Disease Week (DDW), May 21-24, 2016, San Diego, CA, due to publications committee Nov 17, 2015, meeting abstract submission deadline Dec 1, 2015

European Society for Radiotherapy and Oncology (ESTRO), Apr 24-28, 2016, Barcelona, Spain, due to publications committee Nov 6, 2015 , meeting abstract submission deadline Nov 20, 2015

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103